Susan Haigney

Susan Haigney is managing editor of BioPharm International, susan.haigney@ubm.com.

Articles

FDA 2021 Guidance Agenda Sees Focus on Generics

The agency’s focus appears to be on generic drugs for the upcoming year.

Supporting the Industry During a Pandemic

Outsourcing increases as the industry balances development and manufacturing of both COVID-19 treatments and non-pandemic-related medicines.

EDQM Combats COVID-19 and Makes Plans for Future

The European Pharmacopoeia is preparing for 2021 while also supporting the industry to develop vaccines and treatments for COVID-19.

Contractors Balance Increased Demand During COVID-19

The COVID-19 pandemic has created a rise in demand for R&D and a shift in focus for some contract organizations.